SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
03 2021
Historique:
received: 02 10 2020
accepted: 12 02 2021
revised: 31 03 2021
pubmed: 20 3 2021
medline: 13 4 2021
entrez: 19 3 2021
Statut: epublish

Résumé

The first case of SARS-CoV-2 in Basel, Switzerland was detected on February 26th 2020. We present a phylogenetic study to explore viral introduction and evolution during the exponential early phase of the local COVID-19 outbreak from February 26th until March 23rd. We sequenced SARS-CoV-2 naso-oropharyngeal swabs from 746 positive tests that were performed at the University Hospital Basel during the study period. We successfully generated 468 high quality genomes from unique patients and called variants with our COVID-19 Pipeline (COVGAP), and analysed viral genetic diversity using PANGOLIN taxonomic lineages. To identify introduction and dissemination events we incorporated global SARS-CoV-2 genomes and inferred a time-calibrated phylogeny. Epidemiological data from patient questionnaires was used to facilitate the interpretation of phylogenetic observations. The early outbreak in Basel was dominated by lineage B.1 (83·6%), detected first on March 2nd, although the first sample identified belonged to B.1.1. Within B.1, 68·2% of our samples fall within a clade defined by the SNP C15324T ('Basel cluster'), including 157 identical sequences at the root of the 'Basel cluster', some of which we can specifically trace to regional spreading events. We infer the origin of B.1-C15324T to mid-February in our tri-national region. The other genomes map broadly over the global phylogenetic tree, showing several introduction events from and/or dissemination to other regions of the world via travellers. Family transmissions can also be traced in our data. A single lineage variant dominated the outbreak in the Basel area while other lineages, such as the first (B.1.1), did not propagate. A mass gathering event was the predominant initial source of cases, with travel returners and family transmissions to a lesser extent. We highlight the importance of adding specific questions to epidemiological questionnaires, to obtain data on attendance of large gatherings and their locations, as well as travel history, to effectively identify routes of transmissions in up-coming outbreaks. This phylogenetic analysis in concert with epidemiological and contact tracing data, allows connection and interpretation of events, and can inform public health interventions. Trial Registration: ClinicalTrials.gov NCT04351503.

Identifiants

pubmed: 33740028
doi: 10.1371/journal.ppat.1009374
pii: PPATHOGENS-D-20-02170
pmc: PMC8011817
doi:

Banques de données

ClinicalTrials.gov
['NCT04351503']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009374

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Commun. 2020 Sep 1;11(1):4376
pubmed: 32873808
J Med Virol. 2020 Sep;92(9):1637-1640
pubmed: 32222993
J Virol Methods. 2020 Oct;284:113925
pubmed: 32659240
Euro Surveill. 2020 Jul;25(26):
pubmed: 32643599
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Bioinformatics. 2016 Jul 1;32(13):2029-31
pubmed: 27153727
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
BMC Genomics. 2018 Feb 9;19(1):130
pubmed: 29426279
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Biol Direct. 2011 May 26;6:28
pubmed: 21615910
Bioinformatics. 2014 Oct;30(19):2808-10
pubmed: 24903420
Bioinformatics. 2009 Jun 1;25(11):1422-3
pubmed: 19304878
Ecology. 2012 Sep;93(9):2037-51
pubmed: 23094376
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
bioRxiv. 2020 Jun 12;:
pubmed: 32587973
Open Forum Infect Dis. 2020 Sep 18;7(11):ofaa434
pubmed: 33200080
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Wellcome Open Res. 2020 Aug 3;5:184
pubmed: 32995557
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Nat Commun. 2020 Nov 25;11(1):5986
pubmed: 33239633
Swiss Med Wkly. 2020 Feb 27;150:w20212
pubmed: 32227799
J Virol. 2020 Jul 1;94(14):
pubmed: 32357959
Sci Rep. 2020 Oct 20;10(1):17720
pubmed: 33082405
J Infect Dis. 2020 Sep 14;222(8):1270-1279
pubmed: 32726441
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
Front Microbiol. 2020 Jun 25;11:1502
pubmed: 32670259
PLoS One. 2020 Oct 29;15(10):e0241405
pubmed: 33119657
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Mol Biol Evol. 2010 Feb;27(2):221-4
pubmed: 19854763
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Madlen Stange (M)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
Swiss Institute for Bioinformatics, Basel, Switzerland.

Alfredo Mari (A)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
Swiss Institute for Bioinformatics, Basel, Switzerland.

Tim Roloff (T)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
Swiss Institute for Bioinformatics, Basel, Switzerland.

Helena Mb Seth-Smith (HM)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
Swiss Institute for Bioinformatics, Basel, Switzerland.

Michael Schweitzer (M)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.

Myrta Brunner (M)

Human Geography, University of Basel, Basel, Switzerland.

Karoline Leuzinger (K)

Clinical Virology, University Hospital Basel, Basel, Switzerland.
Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.

Kirstine K Søgaard (KK)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.

Alexander Gensch (A)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.

Sarah Tschudin-Sutter (S)

Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.

Simon Fuchs (S)

Health Services for the City of Basel, Basel, Switzerland.

Julia Bielicki (J)

Pediatric Infectious Diseases, University Children's Hospital Basel, Basel, Switzerland.

Hans Pargger (H)

Intensive Care Unit, University Hospital Basel, Basel, Switzerland.

Martin Siegemund (M)

Intensive Care Unit, University Hospital Basel, Basel, Switzerland.

Christian H Nickel (CH)

Emergency Medicine, University Hospital Basel, Basel, Switzerland.

Roland Bingisser (R)

Emergency Medicine, University Hospital Basel, Basel, Switzerland.

Michael Osthoff (M)

Internal Medicine, University Hospital Basel, Basel, Switzerland.

Stefano Bassetti (S)

Internal Medicine, University Hospital Basel, Basel, Switzerland.

Rita Schneider-Sliwa (R)

Human Geography, University of Basel, Basel, Switzerland.

Manuel Battegay (M)

Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.

Hans H Hirsch (HH)

Clinical Virology, University Hospital Basel, Basel, Switzerland.
Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.

Adrian Egli (A)

Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH